Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 02 2019
04 02 2019
Historique:
received:
08
08
2018
accepted:
14
12
2018
entrez:
6
2
2019
pubmed:
6
2
2019
medline:
13
11
2020
Statut:
epublish
Résumé
Niacin inhibits fatty acid flux from adipose tissue to liver, reduces hepatic triglyceride synthesis and increases hepatic lipid oxidation. Thus, niacin may have a role in the regulation of liver fat content in humans. We tested if dietary intake of niacin predicts change of liver fat content during a lifestyle intervention. To this end, we estimated the composition of diet from diaries of 202 healthy subjects at risk of type 2 diabetes undergoing lifestyle intervention comprising physical activity and diet counselling. Total-, subcutaneous- and visceral adipose tissue mass were measured by magnetic resonance (MR) tomography and liver fat content by
Identifiants
pubmed: 30718741
doi: 10.1038/s41598-018-38002-7
pii: 10.1038/s41598-018-38002-7
pmc: PMC6362104
doi:
Substances chimiques
Biomarkers
0
Niacin
2679MF687A
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1303Références
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
J Vitaminol (Kyoto). 1957 Mar 10;3(1):24-9
pubmed: 13429706
J Lipid Res. 2004 Oct;45(10):1835-45
pubmed: 15258194
Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8
pubmed: 15339742
Proc Natl Acad Sci U S A. 1942 Jul;28(7):285-9
pubmed: 16578052
Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):335-48
pubmed: 16932311
Am J Epidemiol. 2007 Aug 1;166(3):260-2
pubmed: 17493951
Gastroenterology. 2007 Aug;133(2):496-506
pubmed: 17681171
J Lipid Res. 2008 Jun;49(6):1195-201
pubmed: 18316796
Gut. 2009 Sep;58(9):1281-8
pubmed: 19074179
J Clin Endocrinol Metab. 2010 Jun;95(6):2727-35
pubmed: 20371660
Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1012-21
pubmed: 21386057
Trends Pharmacol Sci. 2011 Dec;32(12):700-7
pubmed: 21944259
Hepatology. 2012 May;55(5):1389-97
pubmed: 22183689
J Lipid Res. 2012 Apr;53(4):802-9
pubmed: 22315393
Diabetes Care. 2013 Aug;36(8):2331-8
pubmed: 23514731
Curr Opin Lipidol. 2013 Jun;24(3):239-45
pubmed: 23619367
Lancet Diabetes Endocrinol. 2014 May;2(5):406-16
pubmed: 24795254
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
Front Genet. 2015 Apr 20;6:148
pubmed: 25941533
Diabetologia. 2015 Dec;58(12):2877-84
pubmed: 26404062
Hepatology. 2016 Jun;63(6):2032-43
pubmed: 26663351
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Lancet Diabetes Endocrinol. 2016 Sep;4(9):789-798
pubmed: 27185609
Metabolism. 2016 Aug;65(8):1183-95
pubmed: 27301803
Diabetes Care. 2017 Mar;40(3):419-430
pubmed: 28223446
Lancet Diabetes Endocrinol. 2018 Mar;6(3):249-258
pubmed: 28919065
Diabetes Care. 2018 Mar;41(3):398-405
pubmed: 29212824
J Biol Chem. 1973 Jul 25;248(14):5144-9
pubmed: 4146188
Am J Clin Nutr. 1982 Nov;36(5):936-42
pubmed: 7137077